Pharmaceutical Supply – Guaifenesin and Dextromethorphan Hydrobromide

The contract outlines the supply and delivery of 5,000 pharmaceutical units of Guaifenesin and Dextromethorphan Hydrobromide, an over-the-counter medication used for cough and cold relief, to be furnished in full compliance with military logistics standards. This subcontract, issued under the NAICS code 424210 for Pharmaceutical and Pharmacological Product Wholesaling, is managed by the Defense Logistics Agency within the Department of Defense, ensuring alignment with federal procurement protocols and defense supply chain requirements. The agreement specifies fulfillment of quality, packaging, and distribution benchmarks necessary for military use, though exact delivery locations and contact details are not provided. The solicitation was posted on July 17, 2026, and is accessible via the DIBBS portal with the contract reference SPE2DX25D9900 and delivery order SPE2DP26F7739. The contract does not specify a set-aside classification or a designated point of contact, suggesting it may be part of a broader procurement framework managed internally by the agency. All units must meet stringent pharmaceutical and logistical criteria appropriate for military deployment environments, with no indication of alternate sources or exceptions permitted. The absence of geographic details for performance or delivery implies that the items will be distributed according to operational needs across defense installations.